GB9923790D0 - Immunoregulatory compositions - Google Patents

Immunoregulatory compositions

Info

Publication number
GB9923790D0
GB9923790D0 GBGB9923790.1A GB9923790A GB9923790D0 GB 9923790 D0 GB9923790 D0 GB 9923790D0 GB 9923790 A GB9923790 A GB 9923790A GB 9923790 D0 GB9923790 D0 GB 9923790D0
Authority
GB
United Kingdom
Prior art keywords
immunoregulatory compositions
immunoregulatory
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9923790.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9923790.1A priority Critical patent/GB9923790D0/en
Publication of GB9923790D0 publication Critical patent/GB9923790D0/en
Priority to PCT/GB2000/003821 priority patent/WO2001027267A2/en
Priority to EP00969666A priority patent/EP1230357A2/en
Priority to JP2001530471A priority patent/JP2003511070A/en
Priority to AU79325/00A priority patent/AU7932500A/en
Priority to CA002386815A priority patent/CA2386815A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GBGB9923790.1A 1999-10-08 1999-10-08 Immunoregulatory compositions Ceased GB9923790D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9923790.1A GB9923790D0 (en) 1999-10-08 1999-10-08 Immunoregulatory compositions
PCT/GB2000/003821 WO2001027267A2 (en) 1999-10-08 2000-10-06 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions
EP00969666A EP1230357A2 (en) 1999-10-08 2000-10-06 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions
JP2001530471A JP2003511070A (en) 1999-10-08 2000-10-06 Immunomodulating composition
AU79325/00A AU7932500A (en) 1999-10-08 2000-10-06 Immunoregulatory compositions
CA002386815A CA2386815A1 (en) 1999-10-08 2000-10-06 Immunoregulatory compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9923790.1A GB9923790D0 (en) 1999-10-08 1999-10-08 Immunoregulatory compositions

Publications (1)

Publication Number Publication Date
GB9923790D0 true GB9923790D0 (en) 1999-12-08

Family

ID=10862333

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9923790.1A Ceased GB9923790D0 (en) 1999-10-08 1999-10-08 Immunoregulatory compositions

Country Status (6)

Country Link
EP (1) EP1230357A2 (en)
JP (1) JP2003511070A (en)
AU (1) AU7932500A (en)
CA (1) CA2386815A1 (en)
GB (1) GB9923790D0 (en)
WO (1) WO2001027267A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9946836B2 (en) * 2011-01-31 2018-04-17 Robert Bosch Gmbh Biomarker monitoring device and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201905T1 (en) * 1993-10-06 2001-06-15 Icos Corp PLATELE ACTIVATE FACTOR ACETHYL HYDROLASE
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression

Also Published As

Publication number Publication date
WO2001027267A2 (en) 2001-04-19
JP2003511070A (en) 2003-03-25
AU7932500A (en) 2001-04-23
WO2001027267A3 (en) 2002-03-14
CA2386815A1 (en) 2001-04-19
EP1230357A2 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
GB9918180D0 (en) Novel compositions
GB9921037D0 (en) Compositions
GB9904049D0 (en) Rapidly-soluble compositions
GB9902520D0 (en) Composition
AP2001002273A0 (en) Rescorcinol composition
GB2366984B (en) Composition
GB9914446D0 (en) Composition
GB9929622D0 (en) Compositions
GB9904931D0 (en) Compositions
GB9903924D0 (en) Cosmectic compositions
GB9923790D0 (en) Immunoregulatory compositions
GB9926833D0 (en) Compositions
GB2357714B (en) Composition
GB9914582D0 (en) Composition
GB9912421D0 (en) Compositions
GB9926243D0 (en) Compositions
GB9920389D0 (en) Compositions
GB9912423D0 (en) Compositions
GB9912422D0 (en) Compositions
GB9905572D0 (en) Compositions
GB9912420D0 (en) Compositions
GB9904057D0 (en) Compositions
GB9904430D0 (en) Compositions
GB9904599D0 (en) Compositions
GB9905571D0 (en) Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)